Serum-based Protein Profiles of Alzheimer’s Disease and Mild Cognitive Impairment in Elderly Hispanics

References

• World population aging: 1950–2050 . New York : United Nations ( 2001 ). www.un.org/esa/population/publications/worldageing19502050/ .
   Google Scholar
• Ferri CP , PrinceM, BrayneCet al. Global prevalence of dementia: a Delphi consensus study . Lancet366 ( 9503 ), 2112 – 2117 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kalaria RN , MaestreGE, ArizagaRet al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors . Lancet Neurol.7 ( 9 ), 812 – 826 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kinsella K , VelkoffV . An Aging World: 2001. Bureau USC . Washington DC, USA, US Government Printing Office ( 2001 ). www.census.gov/prod/2001pubs/p95–01–1.pdf .
   Google Scholar
• Brea J . Population dynamics in Latin America . Population Reference Bureau, Population Bulletin 58 ( 2003 ). www.igwg.org/Source/58.1PopulDynamicsLatinAmer.pdf .
   Google Scholar
• Palloni A , Pinto-AguirreG, PelaezM . Demographic and health conditions of ageing in Latin America and the Caribbean . Int. J. Epidemiol.31 ( 4 ), 762 – 771 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Nitrini R , BottinoCM, AlbalaCet al. Prevalence of dementia in Latin America: a collaborative study of population-based cohorts . Int. Psychogeriatr.21 ( 4 ), 622 – 630 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Prince M , AcostaD, FerriCPet al. Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study . Lancet380 ( 9836 ), 50 – 58 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sosa AL , AlbaneseE, StephanBCet al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study . PLoS Med.9 ( 2 ), e1001170 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Blennow K , De LeonMJ, ZetterbergH . Alzheimer’s disease . Lancet368 ( 9533 ), 387 – 403 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr , AlbertMS, KnopmanDSet al. Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease . Alzheimers Dement.7 ( 3 ), 257 – 262 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Frey HJ , MattilaKM, KorolainenMA, PirttilaT . Problems associated with biological markers of Alzheimer’s disease . Neurochem. Res.30 ( 12 ), 1501 – 1510 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Hye A , LynhamS, ThambisettyMet al. Proteome-based plasma biomarkers for Alzheimer’s disease . Brain129 ( Pt 11 ), 3042 – 3050 ( 2006 ).
   PubMedGoogle Scholar
• Doecke JD , LawsSM, FauxNGet al. Blood-based protein biomarkers for diagnosis of Alzheimer disease . Arch. Neurol.69 ( 10 ), 1318 – 1325 ( 2012 ).
   PubMedGoogle Scholar
• Laske C , LeyheT, StranskyE, HoffmannN, FallgatterAJ, DietzschJ . Identification of a blood-based biomarker panel for classification of Alzheimer’s disease . Int. J. Neuropsychopharmacol.14 ( 9 ), 1147 – 1155 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , XiaoG, BarberRet al. A blood-based algorithm for the detection of Alzheimer’s disease . Dement. Geriatr. Cogn. Disord.32 ( 1 ), 55 – 62 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , XiaoG, BarberRet al. A serum protein-based algorithm for the detection of Alzheimer disease . Arch. Neurol.67 ( 9 ), 1077 – 1081 ( 2010 ).
   PubMedGoogle Scholar
• O’Bryant SE , XiaoG, ZhangFet al. Validation of a serum screen for Alzheimer’s disease across assay platforms, species, and tissues . J. Alzheimers Dis.42 ( 4 ), 1325 – 1335 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , GuptaV, HenriksenKet al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research . Alzheimers Dement.11 ( 5 ), 549 – 560 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Laske C , SchmohlM, LeyheTet al. Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer’s disease patients . J. Alzheimers Dis.34 ( 2 ), 367 – 375 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Thambisetty M , LovestoneS . Blood-based biomarkers of Alzheimer’s disease: challenging but feasible . Biomark. Med.4 ( 1 ), 65 – 79 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jun G , NajAC, BeechamGWet al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes . Arch. Neurol.67 ( 12 ), 1473 – 1484 ( 2010 ).
   PubMedGoogle Scholar
• O’Bryant SE , XiaoG, EdwardsMet al. Biomarkers of Alzheimer’s disease among Mexican Americans . J. Alzheimers Dis.34 ( 4 ), 841 – 849 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Folstein MF , FolsteinSE, MchughPR . “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician . J. Psychiatr. Res.12 ( 3 ), 189 – 198 ( 1975 ).
   PubMed Web of Science ®Google Scholar
• Blesa R , PujolM, AguilarMet al. Clinical validity of the ‘mini-mental state’ for Spanish speaking communities . Neuropsychologia39 ( 11 ), 1150 – 1157 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Sunderland T , HillJL, MellowAMet al. Clock drawing in Alzheimer’s disease. A novel measure of dementia severity . J. Am. Geriatr. Soc.37 ( 8 ), 725 – 729 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Yesavage JA , BrinkTL, RoseTLet al. Development and validation of a geriatric depression screening scale: a preliminary report . J. Psychiatr. Res.17 ( 1 ), 37 – 49 ( 1982 ).
   PubMed Web of Science ®Google Scholar
• Reisberg B , FerrisSH, De LeonMJ, CrookT . The Global Deterioration Scale for assessment of primary degenerative dementia . Am. J. Psychiatry139 ( 9 ), 1136 – 1139 ( 1982 ).
   PubMed Web of Science ®Google Scholar
• McKhann G , DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM . Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease . Neurology34 ( 7 ), 939 – 944 ( 1984 ).
   PubMed Web of Science ®Google Scholar
• Albert MS , DekoskyST, DicksonDet al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease . Alzheimers Dement.7 ( 3 ), 270 – 279 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mesoscale . www.mesoscale.com .
   Google Scholar
• Mollenhauer B , SteinackerP, BahnEet al. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies . Neurodegener. Dis.4 ( 5 ), 366 – 375 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Shinkai S , ChavesPH, FujiwaraYet al. Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein . Arch. Intern. Med.168 ( 2 ), 200 – 206 ( 2008 ).
   PubMedGoogle Scholar
• Hall JR , JohnsonLA, BarberRCet al. Biomarkers of basic activities of daily living in Alzheimer’s disease . J. Alzheimers Dis.31 ( 2 ), 429 – 437 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Soares HD , PotterWZ, PickeringEet al. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease . Arch. Neurol.69 ( 10 ), 1310 – 1317 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Won E , HurriaA, FengTet al. CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer . Int. J. Gynecol. Cancer23 ( 6 ), 1022 – 1028 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , JohnsonL, EdwardsMet al. The link between C-reactive protein and Alzheimer’s disease among Mexican Americans . J. Alzheimers Dis.34 ( 3 ), 701 – 706 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , XiaoG, BarberRet al. A blood-based screening tool for Alzheimer’s disease that spans serum and plasma: findings from TARC and ADNI . PLoS ONE6 ( 12 ), e28092 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Royall DR , PalmerRF, Texas Alzheimer’s Research and Care Consortium . Does ethnicity moderate dementia’s biomarkers?Neurobiol. Aging35 ( 2 ), 336 – 344 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Saunders AJ , TanziRE . Welcome to the complex disease world. Alpha2-macroglobulin and Alzheimer’s disease . Exp. Neurol.184 ( 1 ), 50 – 53 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Zellner M , VeitingerM, UmlaufE . The role of proteomics in dementia and Alzheimer’s disease . Acta Neuropathol.118 ( 1 ), 181 – 195 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Johnstone D , MilwardEA, BerrettaR, MoscatoP, Alzheimer’s Disease Neuroimaging I . Multivariate protein signatures of pre-clinical Alzheimer’s disease in the Alzheimer’s disease neuroimaging initiative (ADNI) plasma proteome dataset . PLoS ONE7 ( 4 ), e34341 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bossu P , CiaramellaA, SalaniFet al. Interleukin-18, from neuroinflammation to Alzheimer’s disease . Curr. Pharm. Des.16 ( 38 ), 4213 – 4224 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Swardfager W , LanctotK, RothenburgL, WongA, CappellJ, HerrmannN . A meta-analysis of cytokines in Alzheimer’s disease . Biol. Psychiatry68 ( 10 ), 930 – 941 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Xie K , LiuY, HaoWet al. Tenascin-C deficiency ameliorates Alzheimer’s disease-related pathology in mice . Neurobiol. Aging34 ( 10 ), 2389 – 2398 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Brosseron F , KrauthausenM, KummerM, HenekaMT . Body fluid cytokine levels in mild cognitive impairment and Alzheimer’s disease: a comparative overview . Mol. Neurobiol.50 ( 2 ), 534 – 544 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• De Witte L , TomasikJ, SchwarzEet al. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment . Schizophr. Res.154 ( 1 ), 23 – 29 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Motta M , ImbesiR, Di RosaM, StivalaF, MalaguarneraL . Altered plasma cytokine levels in Alzheimer’s disease: correlation with the disease progression . Immunol. Lett.114 ( 1 ), 46 – 51 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Hu WT , Chen-PlotkinA, ArnoldSEet al. Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment . Acta. Neuropathol.119 ( 6 ), 669 – 678 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Garwood CJ , CooperJD, HangerDP, NobleW . Anti-inflammatory impact of minocycline in a mouse model of tauopathy . Front Psychiatry1, 136 ( 2010 ).
   PubMedGoogle Scholar
• Jordanova V , StewartR, DaviesE, SherwoodR, PrinceM . Markers of inflammation and cognitive decline in an African–Caribbean population . Int. J. Geriatr. Psychiatry22 ( 10 ), 966 – 973 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Reale M , KamalMA, VellutoL, GambiD, Di NicolaM, GreigNH . Relationship between inflammatory mediators, Abeta levels and ApoE genotype in Alzheimer disease . Curr. Alzheimer Res.9 ( 4 ), 447 – 457 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Meraz-Rios MA , Toral-RiosD, Franco-BocanegraD, Villeda-HernandezJ, Campos-PenaV . Inflammatory process in Alzheimer’s disease . Front Integr. Neurosci.7, 59 ( 2013 ).
   PubMedGoogle Scholar
• Leonard BE . Inflammation, depression and dementia: are they connected?Neurochem. Res.32 ( 10 ), 1749 – 1756 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Monson NL , IrelandSJ, LigockiAJet al. Elevated CNS inflammation in patients with preclinical Alzheimer’s disease . J. Cereb. Blood Flow Metab.34 ( 1 ), 30 – 33 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Henriksen K , O’BryantSE, HampelHet al. The future of blood-based biomarkers for Alzheimer’s disease . Alzheimers Dement.10 ( 1 ), 115 – 131 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Snyder HM , CarrilloMC, GrodsteinFet al. Developing novel blood-based biomarkers for Alzheimer’s disease . Alzheimers Dement.10 ( 1 ), 109 – 114 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , JohnsonL, BalldinVet al. Characterization of Mexican Americans with mild cognitive impairment and Alzheimer’s disease . J. Alzheimers Dis.33 ( 2 ), 373 – 379 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Crean S , WardA, MercaldiCJet al. Apolipoprotein E epsilon4 prevalence in Alzheimer’s disease patients varies across global populations: a systematic literature review and meta-analysis . Dement. Geriatr. Cogn. Disord.31 ( 1 ), 20 – 30 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gonzalez HM , TarrafW, GouskovaNet al. Neurocognitive function among middle-aged and older Hispanic/Latinos: results from the Hispanic Community Health Study/Study of Latinos . Arch. Clin. Neuropsychol.30 ( 1 ), 68 – 77 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bazenet C , LovestoneS . Plasma biomarkers for Alzheimer’s disease: much needed but tough to find . Biomark. Med.6 ( 4 ), 441 – 454 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• O’Bryant SE , XiaoG, BarberRet al. Molecular neuropsychology: creation of test-specific blood biomarker algorithms . Dement. Geriatr. Cogn. Disord.37 ( 1 ), 45 – 57 ( 2014 ).
   PubMed Web of Science ®Google Scholar